NVAX Competitors & Alternatives
Compare Novavax Inc with similar stocks in the same industry
Biotechnology
NVAX
Main Stock$9.00
Tradestie Score
54
Market Cap
$1.54B
Revenue Growth
-0.8%
Analyst Upside
+56.8%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BHVN
Biohaven Ltd.
|
$15.50
|
$1.57B | - | 61 | Compare |
|
VCEL
Vericel Corporation
|
$40.47
|
$1.56B | 93.3 | 56 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$87.37
|
$1.55B | - | 57 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$33.43
|
$1.55B | 13.4 | 57 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$33.00
|
$1.55B | - | 64 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$17.53
|
$1.50B | 8.1 | 66 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$45.51
|
$1.50B | - | 56 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$16.28
|
$1.49B | - | 55 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$27.23
|
$1.43B | - | 57 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$14.34
|
$1.42B | - | 62 | Compare |
More NVAX Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2836)
222 stocks in this industry